NDC 13537-652-01 - ESIKA PRO MULTI-GLOSS Dual with triple gloss effect SPF 15 (FUCSIA) - PURPLE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-652
- Requested NDC
- 13537-652-01
- Package NDCs from labels
- 13537-652-01, 13537-652-02
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2015-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Octinoxate - Ventura Corporation LTD | Bel Star S.A. (Colombia) | Ventura Corporation LTD | Bel Star S.A. (Colombia) | 2015-03-26 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-652-02 | 2025-03-17 | C162847 | 48780-1 | 9d75b9d1-0a20-f424-e053-dadaa90a57ce | ESIKA PRO MULTI-GLOSS LIPSTICK Dual lipstick with triple gloss effect SPF 15 |
| 13537-652-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0a20-f424-e053-dadaa90a57ce | ESIKA PRO MULTI-GLOSS LIPSTICK Dual lipstick with triple gloss effect SPF 15 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.